Acute-on-chronic liver failure: pathophysiological mechanisms and management

A Khanam, S Kottilil - Frontiers in medicine, 2021 - frontiersin.org
Acute-on-chronic liver failure (ACLF) is a multifaceted condition with poor treatment options
and high short-term mortality. ACLF can develop in patients with or without liver cirrhosis …

Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis

J Lambrecht, LA van Grunsven… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Chronic liver disease is due to various causes of persistent liver damage and
will eventually lead to the development of liver fibrosis. If no treatment is initiated, this …

What do we know about inequalities in NAFLD distribution and outcomes? A scoping review

M Talens, N Tumas, JV Lazarus, J Benach… - Journal of clinical …, 2021 - mdpi.com
With prevalence high and rising given the close relationship with obesity and diabetes
mellitus, non-alcoholic fatty liver disease (NAFLD) is progressively becoming the most …

Liver cirrhosis and immune dysfunction

E Hasa, P Hartmann, B Schnabl - International immunology, 2022 - academic.oup.com
Cirrhosis is end-stage liver disease resulting from various etiologies and is a common cause
of death worldwide. The progression from compensated to decompensated cirrhosis to …

Pathophysiology and management of variceal bleeding

SA Alqahtani, S Jang - Drugs, 2021 - Springer
Cirrhosis is the fifth leading cause of death in adults. Advanced cirrhosis can cause
significant portal hypertension (PH), which is responsible for many of the complications …

The role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification

J Rehm, J Patra, A Brennan, C Buckley… - Drug and alcohol …, 2021 - Wiley Online Library
Issues Alcohol use has been shown to impact on various forms of liver disease, not
restricted to alcoholic liver disease. Approach We developed a conceptual framework based …

Mechanism and effect of HNF4α decrease in a rat model of cirrhosis and liver failure

M Melis, R Marino, J Tian, C Johnson, R Sethi… - Cellular and Molecular …, 2024 - Elsevier
Background & Aims HNF4α, a master regulator of liver development and the mature
hepatocyte phenotype, is down-regulated in chronic and inflammatory liver disease. We …

MRI extracellular volume fraction in liver fibrosis—a comparison of different time points and blood pool measurements

VC Obmann, M Ardoino, J Klaus… - Journal of Magnetic …, 2024 - Wiley Online Library
Background Extracellular volume (ECV) correlates with the degree of liver fibrosis. Purpose
To analyze the performance of liver MRI‐based ECV evaluations with different blood pool …

[HTML][HTML] Vanillic acid alleviates liver fibrosis through inhibiting autophagy in hepatic stellate cells via the MIF/CD74 signaling pathway

L Qin, J Tan, X Lv, J Zhang - Biomedicine & Pharmacotherapy, 2023 - Elsevier
MIF/CD74 signaling pathway and autophagy may be closely related to liver fibrosis. Vanillic
acid (VA) is likely to have an anti-liver fibrosis effect, although related studies have not been …

[HTML][HTML] Potential role of noninvasive biomarkers during liver fibrosis

N Kaur, G Goyal, R Garg, C Tapasvi… - World journal of …, 2021 - ncbi.nlm.nih.gov
Various types of liver disease exist, such as hepatitis and alcoholic liver disease. These liver
diseases can result in scarring of liver tissue, cirrhosis, and finally liver failure. During liver …